Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Profiteer who wrote (1008)	6/17/1998 1:00:00 PM
From: Israel	Respond to of 5402

woops.. they just upticked the bid on no buying or selling.. hmm, i wonder if they're looking for some shares?? Happy trading, Israel

To: Profiteer who wrote (1008)	6/17/1998 1:01:00 PM
From: Richard B. Haenisch	Read Replies (2) \| Respond to of 5402

UPDATE! BID 1 1/32 ASK 1 3/32 TTL VOLUME 226,600 188,700 BUYS 37,900 SELLS RATIO 5:1 BYS OVER SELLS OVER THE LAST 4 TRADING SESSIONS OVER 1,500,000 SHARES WERE SOLD OVER $1 A SHARE - WHAT ARE THE MM WAITING FOR? WHAT DOES IT TAKE TO MOVE THIS STOCK? RICO

To: Profiteer who wrote (1008)	6/17/1998 1:10:00 PM
From: Gwolf	Respond to of 5402

Dr.Drees in a 1994 letter to shareholders stated the following: "How big is the market? The worldwide market for transfusions alone is 60,000,000 transfusions a year. If we did not have to use donor blood, the worldwide market has been estimated by the 'World Health Organization' to be 120,000,000 transfusions at $300 per transfusion or $36 billion a year, which would make PHER-02 the LARGEST DRUG IN HISTORY.Zantec and Tagamet, chronic ulcer drugs, are now about 1/10 of that" Think about, it work through the numbers yourself. Just a little food for thought. Gwolf